2H0
Exicure, Inc. does not have significant operations. Previously, the company focused on developing of nucleic acid therapies targeting ribonucleic acid against validated targets. Exicure, Inc. was founded in 2011 and is headquartered in Redwood City, California.
2H0 (2H0) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.509x
Based on the latest financial reports, 2H0 (2H0) has a cash flow conversion efficiency ratio of -0.509x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-3.53 Million) by net assets (€6.93 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
2H0 - Cash Flow Conversion Efficiency Trend (2021–2024)
This chart illustrates how 2H0's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
2H0 Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of 2H0 ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
bet-at-home.com AG
F:ACX
|
0.301x |
|
Panora Gayrimenkul Yatirim Ortakligi AS
IS:PAGYO
|
0.011x |
|
eMnet Inc
KQ:123570
|
-0.022x |
|
Benton Resources Inc
PINK:BNTRF
|
-0.033x |
|
Dental Corporation Public Company Limited
BK:D
|
0.064x |
|
Anugerah Kagum Karya Utama Tbk PT
JK:AKKU
|
0.000x |
|
ASIASOFT CORP.-NVDR-05
F:5ASA
|
N/A |
|
Stallion Discoveries Corp.
OTCQB:STLNF
|
-0.035x |
Annual Cash Flow Conversion Efficiency for 2H0 (2021–2024)
The table below shows the annual cash flow conversion efficiency of 2H0 from 2021 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | €6.77 Million | €-2.91 Million | -0.430x | +87.42% |
| 2023-12-31 | €3.03 Million | €-10.36 Million | -3.417x | -42.99% |
| 2022-12-31 | €14.92 Million | €-35.66 Million | -2.390x | +22.91% |
| 2021-12-31 | €11.23 Million | €-34.82 Million | -3.100x | -- |